SC 13G
Amended Statement of Ownership
ADMA BIOLOGICS, INC. Filed Acc 0000914208-24-000495
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Invesco Ltd. | 12,793,559 | 5.5% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G · Rubric Capital Management LP 5.51%
- 2026-11-10 SCHEDULE 13G · STATE STREET CORPORATION 6.1%
- 2026-08-07 SCHEDULE 13G · STATE STREET CORPORATION 7.4%
- 2026-04-29 SCHEDULE 13G · Vanguard Capital Management 5.08%
- 2026-03-26 SCHEDULE 13G/A · The Vanguard Group 0%
- 2026-02-12 SCHEDULE 13G/A · Invesco Ltd. 5.0%
- 2025-08-11 SCHEDULE 13G · STATE STREET CORPORATION 5.1%
- 2025-07-29 SCHEDULE 13G/A · The Vanguard Group 8.94%
- 2025-05-13 SCHEDULE 13G · STATE STREET CORPORATION 4.8%
- 2025-05-09 SCHEDULE 13G · Invesco Ltd. 5.4%
- 2025-04-30 SCHEDULE 13G/A · BlackRock, Inc. 15.1%
- 2025-02-07 SCHEDULE 13G/A · Invesco Ltd. 4.8%
- 2024-11-12 SC 13G/A · The Vanguard Group 7.77%
- 2024-11-08 SC 13G · Invesco Ltd. 5.5%
- 2024-11-04 SC 13G · The Vanguard Group 7.77%
Loading SEC13G_Filing.htm…